We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSV
876
DELISTED
Gold Standard Ventures Corp.
GSV
-11,893
Closed -$9.33K
WORK
877
DELISTED
Slack Technologies, Inc.
WORK
-10,700
Closed -$287K
PRVL
878
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-3,700
Closed -$37.7K
HDS
879
DELISTED
HD Supply Holdings, Inc.
HDS
-39
Closed -$1.61K
NBRV
880
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-540
Closed -$71.9K
MYOK
881
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-1,804
Closed -$246K
WMGI
882
DELISTED
Wright Medical Group Inc
WMGI
-126
Closed -$3.85K
IMMU
883
DELISTED
Immunomedics Inc
IMMU
-138
Closed -$11.7K
ZIV
884
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
-2,000
Closed -$54.6K
CRC
885
DELISTED
California Resources Corporation
CRC
-1
Closed
BDSI
886
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-10,923
Closed -$40.7K
AAN.A
887
DELISTED
The Aaron's Company Inc Class A
AAN.A
-1,118
Closed -$63.3K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.